Join
Live feed
·
SECFilingvia Quantisnow
BioCryst Pharmaceuticals Inc. logo

BioCryst Pharmaceuticals Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Results of Operations and Financial Condition, Leadership Update, Other Events, Financial Statements and Exhibits

ByQuantisnow·Wall Street's wire, on your screen.
BCRX· BioCryst Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BCRX (BioCryst Pharmaceuticals Inc.) and more on Quantisnow.